quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:42:27·72d
SECFiling
Ernexa Therapeutics Inc. logo

SEC Form 424B5 filed by Ernexa Therapeutics Inc.

ERNA· Ernexa Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • ERNA
    Ernexa Therapeutics Inc.
    Health Care

Related

  • SEC10d
    SEC Form DEF 14C filed by Ernexa Therapeutics Inc.
  • SEC22d
    SEC Form PRE 14C filed by Ernexa Therapeutics Inc.
  • PR23d
    Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026
  • SEC24d
    SEC Form EFFECT filed by Ernexa Therapeutics Inc.
  • SEC30d
    Amendment: SEC Form S-3/A filed by Ernexa Therapeutics Inc.
  • SEC34d
    SEC Form 8-K filed by Ernexa Therapeutics Inc.
  • SEC41d
    SEC Form 10-K filed by Ernexa Therapeutics Inc.
  • SEC56d
    Ernexa Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022